Transfusion and Haematology Today - Issue 3/2023
171
Hereditary haemorrhagic teleangiectasia (Rendu-Osler-Weber disease)
M. Bradáčová, E. Faber, J. Minařík, F. Čtvrtlík, E. Čecháková
177
Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia – cardiovascular complications and bleeding
A. Panovská, T. Arpáš, M. Šimkovič, M. Špaček, T. Papajík, D. Lysák, L. Bezděková, M. Doubek
Original Papers
186
Covid score – the contribution in prognostic stratification of patients with COVID-19
M. Čerňan, J. Juráňová, J. Kadlecová, T. Szotkowski, J. Zapletalová, T. Papajík
193
Report on the program of the use of convalescent plasma in the treatment of patients with COVID-19 in the Czech Republic and the results of the national multicentre study RESCOVID-19
M. Bohoněk, D. Řezáč, D. Kutáč, P. Vabroušek, J. Kubů, T. Jakub, K. Trojanová, M. Urbánková, A.- Chrdle, K. Volfová, J. Sagan, Š. Blahutová, J. Máca, I. Rychlík, K. Vonášková, R. Majerčin, R. Kralova, P. Štěpánek, M. Holub
Personal News
Transfusion and Haematology Today
2023 Issue 3
Most read in this issue
- Hereditary haemorrhagic teleangiectasia (Rendu-Osler-Weber disease)
- Boris Bubeník slaví sedmdesátiny
- Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia – cardiovascular complications and bleeding
- Teklistamab with the latest two-year effi cacy and safety data in the treatment of RRMM